# Human Brain Mapping of the Apparent Diffusion Coefficient (ADC) During Sleep and Wakefulness

> **NCT02311374** · EARLY_PHASE1 · COMPLETED · sponsor: **National Institute on Alcohol Abuse and Alcoholism (NIAAA)** · enrollment: 40 (actual)

## Conditions studied

- Brain Mapping

## Interventions

- **OTHER:** Brain connectivity and physiology
- **OTHER:** Brain Wave

## Key facts

- **NCT ID:** NCT02311374
- **Lead sponsor:** National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- **Sponsor class:** NIH
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-28
- **Primary completion:** 2018-05-11
- **Final completion:** 2018-05-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02311374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02311374, "Human Brain Mapping of the Apparent Diffusion Coefficient (ADC) During Sleep and Wakefulness". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02311374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*